Three independent discounted-cash-flow-style models value Inspire Medical Systems, Inc. every trading day. 0 of 3 currently price INSP above its market price.
| Free Cash Flow model | $-70.78 |
| Excess Profit model | $-62.07 |
| Residual Earnings model | $-0.51 |
| Dividend Discount model | — |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +5.0% |
| Net debt / EBITDA | -1.5× |
| Gross margin | +85.4% |
| Revenue CAGR | +30.8% |
| Cash conversion | 0.8× |
| Dividend yield | — |
| Buyback yield | +1.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open INSP in StockKitty